NCT04572490

Brief Summary

The study was designed as a retrospective, parallel, two years longitudinal pilot trial. Twenty-eight patients (mean age: 48.34 ± 6.06) aged between 35 and 60 years and 66 TiUnite surfaces (Nobel Biocare Parallel Conical Connection), bone level dental implant were included in the study. The implants were divided into two different groups according to the NPIs and regular platform implants(RPIs). The mean implant lengths, plaque index(PI), gingival index(GI), periodontal pocket depth(PD), gingival recession(GR), keratinized gingival width(KGW) and bleeding on probing(BOP) values were recorded. The Student's t-test used for between-group comparison.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 27, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 24, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 1, 2020

Completed
Last Updated

October 1, 2020

Status Verified

September 1, 2020

Enrollment Period

2 months

First QC Date

September 24, 2020

Last Update Submit

September 30, 2020

Conditions

Keywords

Dental implants Alveolar bone loss

Outcome Measures

Primary Outcomes (1)

  • Marginal bone loss

    Peri-implant alveolar bone loss measurements on software program

    change from baseline marginal bone loss at postoperatively 24. month

Secondary Outcomes (1)

  • Keratinized gingival width

    change from baseline peri-implant keratinized gingival width at postoperatively 24. month

Study Arms (2)

Narrow platform implant

All measurements will be obtained after dental implant functional loading. Periodontal index will be recorded and alveolar bone loss measurements will be made on periapical radiographs.

Diagnostic Test: periapical radiograph

Regular platform implants

All measurements will be obtained after dental implant functional loading. Periodontal index will be recorded and alveolar bone loss measurements will be made on periapical radiographs.

Diagnostic Test: periapical radiograph

Interventions

periapical radiographDIAGNOSTIC_TEST

alveolar bone loss measurement on standardized parallel periapical radiograph

Narrow platform implantRegular platform implants

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All dental implants involved are the Nobel Biocare Parallel CC brand (Nobel Biocare, Gothenburg, Sweden) with a TiUnite surface, and it defined a regular diameter of 4.3 mm and narrow diameter of 3.75 mm. Dental implants divided into two groups according to implant diameter, the NPI group comprised 3.75 mm diameter (NP, Ø= 3.75 mm) implants, and the RPI group comprised 4.3 mm diameter (RP, Ø= 4.3mm) implants (implant lengths: 10 mm-13 mm).

You may qualify if:

  • the presence of a dental implant treated with fixed prosthetic restoration placed in the posterior jaw followed for at least one year after functional loading,
  • no active periodontal disease,
  • no history of penicillin allergy -
  • no radiotherapy to the head and neck region
  • smoking less than ten cigarettes per day,
  • no bone augmentation surgery before or during dental implant surgery,
  • aged over 18,
  • mesial or distal additional crown restoration was not performed,
  • no use of medications that affect bone metabolism and
  • not pregnant or lactating.

You may not qualify if:

  • the implants placed in the anterior region,
  • immediate placing and loading
  • augmented before or using a graft membrane with surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kütahya Health Sciences University Faculty of Dentistry

Kütahya, 43100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Alveolar Bone LossPostoperative Complications

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Berceste Guler, PhD

    Kütahya Health Sciences University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist Prof

Study Record Dates

First Submitted

September 24, 2020

First Posted

October 1, 2020

Study Start

June 27, 2019

Primary Completion

August 31, 2019

Study Completion

October 28, 2019

Last Updated

October 1, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations